1 Min Read
March 27 (Reuters) - DIAMYD MEDICAL AB:
* DIAMYD® SUBCUTANEOUSLY CONTINUES TO SHOW WEAKER RESULTS THAN WHEN ADMINISTERED INTRALYMPHATICALLY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.